Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88241891 |
LAW OFFICE ASSIGNED |
LAW OFFICE 125 |
MARK SECTION |
MARK |
INTERVENN (see, http://uspto.report/TM/88241891/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
INTERVENN |
OWNER SECTION (current) |
NAME |
Venn Biosciences Corporation |
MAILING ADDRESS |
800 Chesapeake Drive |
CITY |
Redwood City |
STATE |
California |
ZIP/POSTAL CODE |
94063 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Venn Biosciences Corporation |
MAILING ADDRESS |
800 Chesapeake Drive |
CITY |
Redwood City |
STATE |
California |
ZIP/POSTAL CODE |
94063 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
Philip R. Zende |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
SQUIRE PATTON BOGGS (US) LLP |
STREET |
275 BATTERY STREET, SUITE 2600 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94111 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-954-0200 |
FAX |
(415) 393-9887 |
EMAIL |
trademark@squirepb.com |
DOCKET/REFERENCE NUMBER |
119759.9 |
ATTORNEY INFORMATION (proposed) |
NAME |
Philip R. Zende |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
SQUIRE PATTON BOGGS (US) LLP |
STREET |
275 BATTERY STREET, SUITE 2600 |
CITY |
SAN FRANCISCO |
STATE |
California |
POSTAL CODE |
94111 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
415-954-0200 |
FAX |
(415) 393-9887 |
EMAIL |
ip-squiretm@squirepb.com |
DOCKET/REFERENCE NUMBER |
119759.00009 |
OTHER APPOINTED ATTORNEY |
Caroline H. Mead, Esq., Francesca C. Ruiz, Esq., Ivan Rothman, Esq., Audrey Y. Nicolson, Esq. and Joseph P. Grasser, Esq. |
CORRESPONDENCE INFORMATION (current) |
NAME |
PHILIP R. ZENDER |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
trademark@squirepb.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
119759.9 |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Philip R. Zende |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ip-squiretm@squirepb.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
james.lyons@squirepb.com |
DOCKET/REFERENCE NUMBER |
119759.00009 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
009 |
CURRENT IDENTIFICATION |
Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of
biological molecules in the nature of proteins, nucleic acids, metabolites and biospecimens in the nature of cells, tissue, and biofluids for use in computing, studying, diagnosing or screening for
diseases and studying biological molecules; Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of post-translational
modifications of proteins for use in computing, studying, diagnosing or screening for diseases and studying biological molecules |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
042 |
CURRENT IDENTIFICATION |
Scientific and medical research services; scientific and medical research services, namely, biomarker and target discovery services for
pharmaceutical development; scientific and medical research services, namely, biomarker discovery and target discovery; providing a database in the field of bioinformatics for medical or scientific
research; providing temporary use of on-line nondownloadable software applications for operating research instrument and medical diagnostic devices for measuring and testing biological molecules and
biospecimens for use in computing, studying, diagnosing or screening for diseases and studying biological molecules; chemical analysis, namely, mass spectrometry services; consulting services in the
field of biotechnology through the application of mass spectrometry; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological
analyses using mass spectrometry, namely, chemical, biochemical, and biological in the nature of protein and cellular analysis; Consulting services in the fields of biotechnology, pharmaceutical
research and development, laboratory testing, diagnostics, and pharmacogenetics |
GOODS OR SERVICES |
KEEP ALL LISTED |
INTERNATIONAL CLASS |
044 |
CURRENT IDENTIFICATION |
Testing and reporting for medical biomarker discovery and validation, target discovery and validation, therapeutics design and development,
patient profiling, treatment prediction and monitoring, and medical diagnostic and prognostic purposes; medical testing for screening, diagnostic, or treatment purposes; medical diagnostic testing,
monitoring, and reporting services; providing a website featuring medical information regarding disease risk factors, disease risk factor analysis, and reporting services for medical purposes |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
09/24/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
3 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
375 |
TOTAL AMOUNT |
375 |
SIGNATURE SECTION |
ORIGINAL PDF FILE |
hw_41573242-185506093_._1
st_Request_for_Extension_ of_Time_to_File_a_Stateme nt_of_Use.pdf |
CONVERTED PDF FILE(S)
(1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\882\418\88241891\xml1\ ESU0002.JPG |
SIGNATORY'S NAME |
Carrascoso, Aldo Mario Eduardo Silva |
SIGNATORY'S POSITION |
CEO |
FILING INFORMATION |
SUBMIT DATE |
Wed Mar 04 19:07:41 ET 2020 |
TEAS STAMP |
USPTO/ESU-X.XX.XX.XXX-202
00304190741877681-8824189
1-710db146bd486e82e516fd1
ceab2d4f8a29590b739b5de4f
dd255f2298ed3e460-DA-0741
3826-20200304185506093657 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: INTERVENN (see, http://uspto.report/TM/88241891/mark.png)
SERIAL NUMBER: 88241891
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Venn Biosciences Corporation, having an address of
800 Chesapeake Drive
Redwood City, California 94063
United States
Proposed: Venn Biosciences Corporation, having an address of
800 Chesapeake Drive
Redwood City, California 94063
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 09/24/2019.
For International Class 009:
Current identification: Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of biological molecules in the nature of
proteins, nucleic acids, metabolites and biospecimens in the nature of cells, tissue, and biofluids for use in computing, studying, diagnosing or screening for diseases and studying biological
molecules; Computer software applications for operating research instrument and medical diagnostic devices for measuring, testing and analysis of post-translational modifications of proteins for use
in computing, studying, diagnosing or screening for diseases and studying biological molecules
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 042:
Current identification: Scientific and medical research services; scientific and medical research services, namely, biomarker and target discovery services for pharmaceutical development; scientific
and medical research services, namely, biomarker discovery and target discovery; providing a database in the field of bioinformatics for medical or scientific research; providing temporary use of
on-line nondownloadable software applications for operating research instrument and medical diagnostic devices for measuring and testing biological molecules and biospecimens for use in computing,
studying, diagnosing or screening for diseases and studying biological molecules; chemical analysis, namely, mass spectrometry services; consulting services in the field of biotechnology through the
application of mass spectrometry; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological analyses using mass spectrometry,
namely, chemical, biochemical, and biological in the nature of protein and cellular analysis; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory
testing, diagnostics, and pharmacogenetics
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
For International Class 044:
Current identification: Testing and reporting for medical biomarker discovery and validation, target discovery and validation, therapeutics design and development, patient profiling, treatment
prediction and monitoring, and medical diagnostic and prognostic purposes; medical testing for screening, diagnostic, or treatment purposes; medical diagnostic testing, monitoring, and reporting
services; providing a website featuring medical information regarding disease risk factors, disease risk factor analysis, and reporting services for medical purposes
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
Philip R. Zende SQUIRE PATTON BOGGS (US) LLP
275 BATTERY STREET, SUITE 2600
SAN FRANCISCO, California 94111
United States
Phone: 415-954-0200
Fax: (415) 393-9887
The docket/reference number is 119759.9
Email: trademark@squirepb.com
The applicant's proposed Attorney Information:
Philip R. Zende SQUIRE PATTON BOGGS (US) LLP
275 BATTERY STREET, SUITE 2600
SAN FRANCISCO, California 94111
United States
Phone: 415-954-0200
Fax: (415) 393-9887
The docket/reference number is 119759.00009
Email: ip-squiretm@squirepb.com
Correspondence Information (current):
PHILIP R. ZENDER
PRIMARY EMAIL FOR CORRESPONDENCE: trademark@squirepb.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Philip R. Zende
PRIMARY EMAIL FOR CORRESPONDENCE: ip-squiretm@squirepb.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): james.lyons@squirepb.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $375 will be submitted with the form, representing payment for 3 classes.
Declaration
Original PDF file:
hw_41573242-185506093_._1
st_Request_for_Extension_ of_Time_to_File_a_Stateme nt_of_Use.pdf
Converted PDF file(s) (1 page)
Signature File1
Signatory's Name: Carrascoso, Aldo Mario Eduardo Silva
Signatory's Position: CEO
Mailing Address:
SQUIRE PATTON BOGGS (US) LLP
275 BATTERY STREET, SUITE 2600
SAN FRANCISCO, California 94111
RAM Sale Number: 88241891
RAM Accounting Date: 03/04/2020
Serial Number: 88241891
Internet Transmission Date: Wed Mar 04 19:07:41 ET 2020
TEAS Stamp: USPTO/ESU-X.XX.XX.XXX-202003041907418776
81-88241891-710db146bd486e82e516fd1ceab2
d4f8a29590b739b5de4fdd255f2298ed3e460-DA
-07413826-20200304185506093657